Selective serotonin re‐uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatment - Teichert, Martina; Visser, Loes E.; Uitterlinden, Andrė G.; Hofman, Albert; Buhre, Peter J.; Straus, Sabine; De Smet, Peter A. G. M.; Stricker, Bruno HCh (British journal of clinical pharmacology, 2011)
Keywords: acenocoumarol; Acenocoumarol - therapeutic use; Aged; Aged, 80 and over; Anticoagulants; Anticoagulants - therapeutic use; Antidepressants; Antidepressive Agents - pharmacology; Biological and medical sciences; Bleeding; Blood Coagulation - drug effects; Case reports; Cohort Studies; Coumarin; Cyclohexanols - pharmacology; Drug abuse; Drug Interactions; Drugs; Fluoxetine; fluvoxamine; Fluvoxamine - pharmacology; Hemorrhage - chemically induced; Humans; Medical sciences; Middle Aged; paroxetine; Pharmacology. Drug treatments; Population studies; Proportional Hazards Models; prothrombin; Risk Factors; selective serotonin re‐uptake inhibitors; Serotonin - pharmacology; Serotonin uptake inhibitors; Serotonin Uptake Inhibitors - pharmacology; Venlafaxine; Venlafaxine Hydrochloride; Warfarin; Serotonin; Psychotropic; Coumarine derivatives; Overdosing; selective serotonin re-uptake inhibitors; Phénéthylamine derivatives; Anticoagulant; Catecholamine; Reuptake inhibitor; Uptake; Selective serotonin reuptake inhibitor; Antivitamin K; Maintenance treatment; Risk factor; Neurotransmitter; Antidepressant agent; Venlafaxine; Norepinephrine; Fluvoxamine; Acenocoumarol